| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/15/2006 | WO2005092380A3 Uses of anti-ctla-4 antibodies |
| 06/15/2006 | WO2005086698A3 Methods for altering t cell diversity |
| 06/15/2006 | WO2005072777A3 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 06/15/2006 | WO2005013915A3 Novel indications for transforming growth factor-beta regulators |
| 06/15/2006 | WO2004087887A3 Intracellular complexes as biomarkers |
| 06/15/2006 | US20060130170 Avian transgenesis using a chicken ovalbumin gene region |
| 06/15/2006 | US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP) |
| 06/15/2006 | US20060130160 Full-length human cDNAs encoding potentially secreted proteins |
| 06/15/2006 | US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity |
| 06/15/2006 | US20060128616 Process for the purification of tnf-binding proteins using imac |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060127983 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/15/2006 | US20060127979 Capable of generating high titer neutralizing antibody responses against at least two HPV types; prophylactic agents; diagnosis |
| 06/15/2006 | US20060127962 Biomarkers for intro-amniotic inflammation |
| 06/15/2006 | US20060127959 Antibodies that bind M. tuberculosis polypeptides |
| 06/15/2006 | US20060127955 Assay for autoantibodies to folate receptors |
| 06/15/2006 | US20060127954 N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses |
| 06/15/2006 | US20060127949 Construct comprising two antigen binding sites where both have a moiety with a molecule binding region and a molecule non-binding region; detecting protein having certain amino acid sequences |
| 06/15/2006 | US20060127941 Nuclear matrix protein fluid assay |
| 06/15/2006 | US20060127937 Novel Survivin interacting protein TPR1 |
| 06/15/2006 | US20060127927 Mammalian IAP gene family, primers, probes, and detection methods |
| 06/15/2006 | US20060127921 PECAM-1-related molecules compositions kit of parts and associated methods of use |
| 06/15/2006 | US20060127903 Marker for cancer |
| 06/15/2006 | US20060127897 Delete sequence in m, tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 06/15/2006 | US20060127894 Protein associated with cell growth, differentiation, and death |
| 06/15/2006 | US20060127893 Modification of human variable domains |
| 06/15/2006 | US20060127890 Novel gene overexpressed in heart and skeletal muscle and use thereof |
| 06/15/2006 | US20060127416 Polynucleotide encoding a protein believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens. |
| 06/15/2006 | US20060127407 Anti-integrin immunoconjugates, methods and uses |
| 06/15/2006 | US20060127406 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
| 06/15/2006 | US20060127405 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 06/15/2006 | US20060127404 Hinge core mimetibodies, compositions, methods and uses |
| 06/15/2006 | US20060127403 Use of antibodies against tumor-associated antigen |
| 06/15/2006 | US20060127402 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 06/15/2006 | US20060127398 Monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 06/15/2006 | US20060127397 RAG polypeptides, nucleic acids, and their use |
| 06/15/2006 | US20060127396 Peptide fragment of lyve-1 and antibody against the same |
| 06/15/2006 | US20060127395 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease |
| 06/15/2006 | US20060127393 antibodies and antigen binding domains and CDR regions that mediate selective binding to an epitope located in the carboxyl half of the Dkk-1 protein; for bone disorders, inflammatory, neurological, ocular, renal, pulmonary and skin diseases |
| 06/15/2006 | US20060127392 Antibody for adcc and inducing cytokine production |
| 06/15/2006 | US20060127391 Methods and materials for treating inflammatory conditions |
| 06/15/2006 | US20060127388 Variants of glycogen synthase kinase 3 and uses thereof |
| 06/15/2006 | US20060127356 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology |
| 06/15/2006 | US20060127327 Monoclonal antibodies specific for cariogenic bacteria |
| 06/15/2006 | US20060127310 Amplification of biotin-mediated targeting |
| 06/15/2006 | CA2614574A1 Cytotoxic agents comprising new c-2 modified taxanes |
| 06/15/2006 | CA2600898A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | CA2591297A1 Il-7 variants with reduced immunogenicity |
| 06/15/2006 | CA2591148A1 Anti-integrin immunoconjugates, methods and uses |
| 06/15/2006 | CA2590284A1 Recombinant method for making multimeric proteins |
| 06/15/2006 | CA2590196A1 Use of pta peptides for stratification of individuals having cancer |
| 06/15/2006 | CA2589759A1 Monoclonal and polyclonal antibodies to equine hemoglobin and apparatus and methods using the antibodies and/or peroxidase reactions in the identification and localization of ulcers in equines |
| 06/15/2006 | CA2588587A1 Cytotoxic agents comprising new taxanes |
| 06/15/2006 | CA2587143A1 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 06/15/2006 | CA2585104A1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 06/14/2006 | EP1669453A1 Novel nerve stem cell marker |
| 06/14/2006 | EP1669451A1 Brain tumor marker and method of diagnosing brain tumor |
| 06/14/2006 | EP1669371A2 Composition and methods for the diagnosis of tumours |
| 06/14/2006 | EP1669358A1 Cytotoxic agents comprising new taxanes |
| 06/14/2006 | EP1668161A2 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways |
| 06/14/2006 | EP1668132A1 Cytokine involved in epithelial-mesenchymal transition |
| 06/14/2006 | EP1668112A2 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and essays for making and using |
| 06/14/2006 | EP1668111A2 Osteoarthritis biomarkers and uses thereof |
| 06/14/2006 | EP1668036A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 06/14/2006 | EP1668035A2 Monoclonal antibodies against hmgb1 |
| 06/14/2006 | EP1668034A1 Pro-inflammatory and anti-inflammatory antibodies against the heparin-binding protein (hbp) |
| 06/14/2006 | EP1668033A2 Nogo-a binding molecules with enhanced affinity and pharmaceutical use thereof |
| 06/14/2006 | EP1668026A1 Detection of cholesterol ozonation products |
| 06/14/2006 | EP1668025A2 Seneca valley virus based compositions and methods for treating disease |
| 06/14/2006 | EP1667730A2 Compositions and methods for treating inflammatory lung disease |
| 06/14/2006 | EP1667718A2 Method of promoting graft survival with anti-tissue factor antibodies |
| 06/14/2006 | EP1667717A2 Therapeutic human anti-mhc class ii antibodies and their uses |
| 06/14/2006 | EP1667716A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 06/14/2006 | EP1667713A1 Measles subunit vaccine |
| 06/14/2006 | EP1379650B1 Preferred segments of neural thread protein and methods of using the same |
| 06/14/2006 | EP1309703B1 Kallikrein gene |
| 06/14/2006 | EP1278825B1 Methods of producing membrane vesicles |
| 06/14/2006 | EP1255558B1 Anti-april antibodies and hybridoma cells |
| 06/14/2006 | EP1200597B1 Method for preparing 1,3-propanediol by a recombinant micro-organism in the absence of coenzyme b12 or one of its precursors |
| 06/14/2006 | EP1119370B1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 06/14/2006 | EP1097210B1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 06/14/2006 | EP1045926B1 Gene family with transformation modulating activity |
| 06/14/2006 | EP1033373B1 Feline granulocyte colony-stimulating factor |
| 06/14/2006 | EP0964869B1 Methods and compositions for the treatment of neoplastic diseases |
| 06/14/2006 | EP0956360B1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses |
| 06/14/2006 | EP0934072B1 Manufacturing process for the production of purified transferrin |
| 06/14/2006 | EP0913404B1 Differentiation inhibitor |
| 06/14/2006 | EP0795605B1 Denatured low-density lipoprotein receptor |
| 06/14/2006 | EP0760867B1 Compositions and methods relating to dna mismatch repair genes |
| 06/14/2006 | EP0750509B2 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 06/14/2006 | EP0699236B2 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 06/14/2006 | EP0666868B2 Use of anti-VEGF antibodies for the treatment of cancer |
| 06/14/2006 | DE102004059357A1 New antibody (which specifically recognizes human thiamine 1) useful for blocking the binding of human Thy-1 at its ligand or for blocking the interaction of tumor cells or immune cells with endothelial cells |
| 06/14/2006 | CN1788019A Neutralizing antibodies against GDF-8 and uses therefor |
| 06/14/2006 | CN1788018A Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS 06 of pseudomonas aeruginosa |
| 06/14/2006 | CN1787839A Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 06/14/2006 | CN1787838A Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 06/14/2006 | CN1787837A Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 06/14/2006 | CN1787741A Methods and compositions for the prevention and treatment of sepsis |
| 06/14/2006 | CN1786156A Anti HBeAg monoclone antibody cell strain, preparation method and anti HBeAg monoclone antibody |